Published in Endocr Rev on June 01, 2003
Retracted Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results from the National Institutes of Health--National Heart, Lung, and Blood Institute sponsored Women's Ischemia Syndrome Evaluation. J Clin Endocrinol Metab (2008) 2.21
Testosterone and visceral fat in midlife women: the Study of Women's Health Across the Nation (SWAN) fat patterning study. Obesity (Silver Spring) (2009) 1.49
Impact of obesity on the risk for polycystic ovary syndrome. J Clin Endocrinol Metab (2007) 1.44
Brown adipose tissue transplantation ameliorates polycystic ovary syndrome. Proc Natl Acad Sci U S A (2016) 1.40
Carotid artery intima-media thickness in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update (2011) 0.97
Searching for polycystic ovary syndrome in postmenopausal women: evidence of a dose-effect association with prevalent cardiovascular disease. Menopause (2007) 0.95
Polycystic ovary syndrome in adolescence. Endocrinol Metab Clin North Am (2005) 0.93
PCOS Forum: research in polycystic ovary syndrome today and tomorrow. Clin Endocrinol (Oxf) (2011) 0.91
Poly Cystic Ovarian Syndrome: An Updated Overview. Front Physiol (2016) 0.90
Developmental androgen excess programs sympathetic tone and adipose tissue dysfunction and predisposes to a cardiometabolic syndrome in female mice. Am J Physiol Endocrinol Metab (2013) 0.90
Metabolomics reveals reduction of metabolic oxidation in women with polycystic ovary syndrome after pioglitazone-flutamide-metformin polytherapy. PLoS One (2011) 0.86
Role of haptoglobin in polycystic ovary syndrome (PCOS), obesity and disorders of glucose tolerance in premenopausal women. PLoS One (2009) 0.86
MTHFR C677T polymorphism is associated with hyperlipidemia in women with polycystic ovary syndrome. J Hum Reprod Sci (2012) 0.85
Ovarian hypertension: polycystic ovary syndrome. Endocrinol Metab Clin North Am (2011) 0.85
Risk of cardiovascular events in mothers of women with polycystic ovary syndrome. Endocr Pract (2008) 0.84
Menstrual health and the metabolic syndrome in adolescents. Ann N Y Acad Sci (2008) 0.84
Serum uric acid in relation to endogenous reproductive hormones during the menstrual cycle: findings from the BioCycle study. Hum Reprod (2013) 0.84
Genetics of polycystic ovary syndrome. Hippokratia (2009) 0.84
Evidence for increased cardiovascular events in the fathers but not mothers of women with polycystic ovary syndrome. Hum Reprod (2011) 0.84
TNF-α haplotype association with polycystic ovary syndrome - a South Indian study. J Assist Reprod Genet (2013) 0.83
Association of Gly972Arg variant of insulin receptor subtrate-1 and Gly1057Asp variant of insulin receptor subtrate-2 with polycystic ovary syndrome in the Chinese population. J Ovarian Res (2014) 0.83
4G/5G polymorphism of PAI-1 gene and Alu-repeat I/D polymorphism of TPA gene in Turkish patients with polycystic ovary syndrome. J Assist Reprod Genet (2007) 0.83
Prevalence of metabolic syndrome in women with polycystic ovary syndrome attending an infertility clinic in a tertiary care hospital in south India. J Hum Reprod Sci (2012) 0.83
Is interleukin-18 associated with polycystic ovary syndrome? Reprod Biol Endocrinol (2011) 0.82
Polycystic ovary syndrome and its impact on women's quality of life: More than just an endocrine disorder. Drug Healthc Patient Saf (2009) 0.81
Longterm management of Polycystic Ovarian Syndrome (PCOS). Mol Cell Endocrinol (2012) 0.81
Do ACE I/D gene polymorphism serve as a predictive marker for age at onset in PCOS? J Assist Reprod Genet (2012) 0.80
The progesterone receptor PROGINS polymorphism is not related to oxidative stress factors in women with polycystic ovary syndrome. Cardiovasc Diabetol (2007) 0.80
The Genetic Basis of the Polycystic Ovary Syndrome: A Literature Review Including Discussion of PPAR-gamma. PPAR Res (2007) 0.80
Cardiovascular Disease and 10-Year Mortality in Postmenopausal Women with Clinical Features of Polycystic Ovary Syndrome. J Womens Health (Larchmt) (2016) 0.80
Levels of Neopterin and other Inflammatory Markers in Obese and Non-Obese Patients with Polycystic Ovary Syndrome. Med Sci Monit (2015) 0.79
Copeptin, a surrogate marker for arginine vasopressin, is associated with cardiovascular risk in patients with polycystic ovary syndrome. J Ovarian Res (2014) 0.79
Obstructive sleep apnea and metabolic dysfunction in polycystic ovary syndrome. Best Pract Res Clin Endocrinol Metab (2010) 0.78
Cadmium and Reproductive Health in Women: A Systematic Review of the Epidemiologic Evidence. Curr Environ Health Rep (2014) 0.78
Heart type fatty acid binding protein response and subsequent development of atherosclerosis in insulin resistant polycystic ovary syndrome patients. J Ovarian Res (2012) 0.77
The metabolic effects of drugs used for the treatment of polycystic ovary syndrome. J Turk Ger Gynecol Assoc (2013) 0.77
Early Biomarkers of Subclinical Atherosclerosis in Obese Adolescent Girls with Polycystic Ovary Syndrome. J Pediatr (2015) 0.77
Prevalence of vitamin D deficiency in Slovak women with polycystic ovary syndrome and its relation to metabolic and reproductive abnormalities. Wien Klin Wochenschr (2015) 0.76
Prevalence of ultrasonography proved polycystic ovaries in North Indian women with type 2 diabetes mellitus. Reprod Biol Endocrinol (2005) 0.76
Afamin serum concentrations are associated with insulin resistance and metabolic syndrome in polycystic ovary syndrome. Reprod Biol Endocrinol (2014) 0.76
A new perspective in diagnosing polycystic ovary syndrome. J Natl Med Assoc (2007) 0.75
The Association of -429T>C and -374T>A Polymorphisms in the RAGE Gene with Polycystic Ovary Syndrome. Int J Med Sci (2016) 0.75
Melatonin and its correlation with testosterone in polycystic ovarian syndrome. J Hum Reprod Sci (2013) 0.75
High Serum Tumor Necrosis Factor-Alpha Levels in Women with Polycystic Ovary Syndrome: A Meta-Analysis. PLoS One (2016) 0.75
Progesterone levels on the hCG day and outcomes in vitro fertilization in women with polycystic ovary syndrome. J Assist Reprod Genet (2012) 0.75
Does Carotid Intima-media Thickness have Relationship with Polycystic Ovary Syndrome? Int J Prev Med (2013) 0.75
Is there any relationship between different phenotypes of metabolic syndrome and cardiovascular mortality rate? Adv Biomed Res (2016) 0.75
MECHANISMS IN ENDOCRINOLOGY: The sexually dimorphic role of androgens in human metabolic disease. Eur J Endocrinol (2017) 0.75
Frequency of nodular goiter and autoimmune thyroid disease and association of these disorders with insulin resistance in polycystic ovary syndrome. J Turk Ger Gynecol Assoc (2017) 0.75
Type 2 diabetes and polycystic ovary syndrome. Fertil Steril (2006) 0.81
Superovulation and multiple birth: in search of kryptonite. Fertil Steril (2012) 0.75
Barriers to conducting clinical research in reproductive medicine: United States of America. Fertil Steril (2011) 0.75